# Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

> **NCT04267887** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **OHSU Knight Cancer Institute** · enrollment: 7 (actual)

## Conditions studied

- Castration-Sensitive Prostate Carcinoma
- Metastatic Prostate Carcinoma
- Stage IVB Prostate Cancer AJCC v8

## Interventions

- **DRUG:** Abiraterone Acetate
- **DRUG:** Antiandrogen Therapy
- **DRUG:** Apalutamide
- **DRUG:** Prednisone
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Bone Scan
- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT04267887
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-05-11
- **Primary completion:** 2028-01-01
- **Final completion:** 2030-01-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04267887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04267887, "Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04267887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*